Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The Company also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.
BörsenkürzelAKAN
Name des UnternehmensAkanda Corp
IPO-datumMar 15, 2022
CEOMs. Katharyn (Katie) Field
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeMar 15
Addresse1A, 1B Learoyd Road
StadtNEW ROMNEY
BörseNASDAQ Capital Market Consolidated
LandUnited Kingdom
PostleitzahlTN28 8XU
Telefon442034889514
Websitehttps://akandacorp.com/
BörsenkürzelAKAN
IPO-datumMar 15, 2022
CEOMs. Katharyn (Katie) Field
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten